Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-12003169Phase 4Completed
Phase 4, open-label trial of shenfu injection in cardiac arrest (SCA) (2 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoint: admission survival rate. Started Sep 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-12003169.